Navigation Links
Mesenchymal Stem Cell Research Activity Rose 116% in 2011; Businesses Turning to BioInformant Worldwide for MSC Market Research
Date:7/25/2012

FARMINGTON, Conn., July 25, 2012 /PRNewswire-iReach/ -- Businesses looking to capture a larger slice of the lucrative mesenchymal stem cell product market need the best market research to stay ahead of the competition. Global Information Inc, in partnership with research firm BioInformant Worldwide, is pleased to present three new reports on stem cells and regenerative medicine. This new research will help businesses in the stem cell industry understand their customers by providing insight into the needs of research scientists; boost effective product development decisions; streamline marketing budgets; learn how to gain more market share; understand the key strengths and weaknesses of competitors and identify opportunities.

(Logo: http://photos.prnewswire.com/prnh/20120725/CG46150)

Mesenchymal Stem Cells – Advances & Applications

In BioInformant's recently launched market report, analysis of grant activity, publications, and patent applications reveals that Mesenchymal Stem Cell (MSC) research activity increased 112% from 2009 to 2010, and 116% from 2010 to 2011. Mesenchymal stem cells now represent fastest growing area of stem cell research.  While competitors are guessing, this report divulges exactly where to focus R&D and marketing spend to create the most profitable MSC research products.

The new report identifies recent advances in MSC research applications, explores research priorities by market segment, highlights individual labs and end-users of MSC research products, explores the competitive environment for MSC research products, and provides 5-year growth and trend analysis. It is your guide for how to profit from the mesenchymal stem cell (MSC) product market – the fastest growing area of stem cell research. 

To view free products samples and a full Table of Contents, visit: http://www.giiresearch.com/report/biof234291-mesenchymal-stem-cells-advances-applications.html

Complete 2012 U.S. Cord Blood Banking Industry Report

As of 2012, the cord blood banking industry is one of the fastest growing industries in the world. There were only 23 active cord blood banks as of 2005, and now just 7 years later, there are 485 worldwide. Cord blood banks now exist in nearly every developed country, as well as several developing nations. That is a 21-fold increase (2,100%) in the companies involved in the industry, over only a seven year period. This rapid market growth represents both an opportunity to profit, as well as swarming competition.

This industry report is a comprehensive road-map for operating a successful cord blood bank. It takes you from the where the industry has been, to where it is now, to where is going in the next five years. In addition, it gives you insider knowledge of how expectant parents think, so you can get there fast.

An Executive Summary of this analysis and a free sample of the full report are available at http://www.giiresearch.com/report/biof247398-complete-2012-us-cord-blood-banking-industry.html

Error-Proof Entry, Expert Positioning, and Exploding Growth in Embryonic Stem Cell Products

The potential medical advances made possible from the use of human embryonic stem cells (hESC) are huge. These stem cells are able to develop into any of over 200 different cell types. So it's no surprise that the scientific research community is enthusiastically exploring all possibilities.

And where there is significant and growing interest from scientists, there is an opportunity for a company like yours to increase revenue from supplying stem cell products. There is no doubt it's an exciting market in which to expand your product range. But with embryonic stem cells there are serious market entry barriers to consider - namely a complex intellectual property scene.

This market research report explores the complex IP landscape affecting development of human embryonic stem cell products, providing clear guidance for companies entering or already within the market, from collaborating with WARF to less costly alternatives - such as circumventing the claims, conducting research off-shore, and developing embryonic stem cell products for other species.

An Executive Summary of this analysis and a free sample of the full report are available at http://www.giiresearch.com/report/biof242923-opportunities-human-embryonic-stem-cell-product.html

About Global Information Inc. Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.

Media Contact: Jeremy Palaia Global Information, Inc., 1-860-674-8796, Press@gii.co.jp

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Global Information, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Sigma-Aldrich Accelerates Analytical Research and Extends Benefits of Fused-Core Particle Technology to All HPLC Users with the Launch of New Ascentis Express 5 Micron Particle by Supelco
2. Speakers Announced for the 2012 International Iridoid Research Symposium
3. Joslin Diabetes Center Convenes Leaders in Diabetes Prevention, Treatment, Payment, Education and Research at Diabetes Innovation 2012
4. ViiV Healthcare Expands Commitment to Addressing Gaps in Paediatric HIV Research, Care and Treatment
5. University of Ottawa Medical Research Arm Eliminates Storage Boundaries with EMC Isilon
6. Promotional Trends Report from Encuity Research Shows Maneuvering to Fill Lipitor Vacuum
7. Enteral Feeding Devices Industry is Expected to Reach USD 2,447.6 Million Globally in 2018: Transparency Market Research
8. CVS Caremark Research Identifies Positive Link Between Medication Adherence and Employee Productivity
9. ResearchMoz.US: Direct to Consumer (DTC) Advertising in Pharmaceuticals - Shift From Traditional Mass-Media Platforms Towards Personalization via Online and Social Media- Market Research Report
10. AstraZeneca and Leading Academic Scientists to Collaborate on Alzheimers Disease Research
11. Researchers Developing New Multiple Sclerosis Drug That Can Be Taken Orally
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... May 24, 2016 Celsion Corporation (NASDAQ: ... company, today provided an update on its ongoing ... trial combining GEN-1, the Company,s DNA-based immunotherapy, with ... newly-diagnosed patients with advanced ovarian cancer who will ... GEN-1 is an IL-12 DNA plasmid vector formulated ...
(Date:5/24/2016)... May 24, 2016 The ... world , s first dual therapy stent, ...   OrbusNeich, a global company specializing in ... portfolio to include products to treat peripheral artery disease. ... first entry devices for lower limb and arteriovenous (AV) ...
(Date:5/24/2016)... , May 24, 2016 ... ™ , la première endoprothèse à ... destinés à l,intervention portant sur les membres ... OrbusNeich, entreprise mondiale spécialisée dans ... changer la vie, a élargi son portefeuille ...
Breaking Medicine Technology:
(Date:5/26/2016)... ... May 26, 2016 , ... ... of thousands of defective respirators, according to court documents and SEC filings. ... William and Becky Tyler v. American Optical Corporation, Case No. BC588866, Los Angeles ...
(Date:5/26/2016)... ... May 26, 2016 , ... Connor Sports, through its ... partner for the Tamika Catchings Legacy Tour that will commemorate the Indiana ... hardwood basketball surfaces in all forms and levels of the game, Connor Sports has ...
(Date:5/26/2016)... Pittsburgh, PA (PRWEB) , ... May 26, 2016 ... ... transplantation, and one that has a significant negative impact on long-term patient survival, ... to date. The results, published online this week in the Journal of Thoracic ...
(Date:5/26/2016)... ... May 26, 2016 , ... Catalent Pharma Solutions, ... biologics, consumer health and global clinical supply services, today announced two key appointments ... company’s continued investment and strategic growth plans in the Asia Pacific region. , ...
(Date:5/26/2016)... ... ... effort to provide hair restoration information to the widest possible audience, Dr. Parsa Mohebi is ... the app. Dr. Mohebi, the founder of Parsa Mohebi Hair Restoration, is making all of ... Mohebi says, “The positive response to the Snapchat videos we started last month has been ...
Breaking Medicine News(10 mins):